Adam Morin

DCOne as an Allogeneic Cell-based Vaccine for Multiple Myeloma

A. Kruisbeek, J. Rosenblatt, D. Avigan, 2017, Journal of immunotherapy.

Inactivated SARS-CoV-2 Reprograms the Tumor Immune Microenvironment and Improves Murine Cancer Outcomes

A. Zloza, Adam Morin, E. Giurini, 2022, bioRxiv.

Potent Synergy between Combination of Chimeric Antigen Receptor (CAR) Therapy Targeting CD19 in Conjunction with Dendritic Cell (DC)/Tumor Fusion Vaccine in Hematological Malignancies.

N. Munshi, M. Capelletti, M. Sadelain, 2020 .

Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T-cell responses in a murine acute myeloid leukemia model

M. Bhasin, B. Ebert, G. Freeman, 2021, Haematologica.

Development of Novel Second Generation DC/Tumor Fusion Vaccine in Lymphoma

M. Capelletti, D. Kufe, R. Joyce, 2019, Biology of Blood and Marrow Transplantation.